Articles

Kelley Blue Book: The 2024 Nissan GT-R review: An old-school sports car that delivers high-performance thrills

The high-performance 2024 Nissan GT-R coupe still has the capacity to thrill, despite being somewhat old-school in today’s automotive world.

Next Avenue: Vibrating shoe insoles are just part of a new wave of health sensors that are shaking things up

New innovations in digital technologies are increasingly providing valuable, real-time data to assist with healthy aging and geriatric care.

NerdWallet: How the travel industry is tapping into the mocktail market

Bars in popular destinations, hotels and cruise lines are moving beyond ultra-sweet mocktails and creating nonalcoholic craft options.

Market Snapshot: Futures point to Nasdaq sliding further into correction territory as Meta shares retreat

U.S. stock futures fell as shares in Meta pulled back following results and bond yields hovered near recent highs.

: This bank that serves cannabis customers had most of its profit wiped out by a robbery.

Parke Bancorp reported a 90% decline in third-quarter profit after a robbery.

MarketWatch First Take: Meta is making a risky bet as it spends boatloads on AI despite rocky ad market

Meta plans to spend boatloads on building out AI infrastructure next year, even as it admits that the advertising landscape could be choppy.

: Biden asks Congress for $16 billion to reverse child-care funding ‘cliff’

As child-care centers face an uncertain funding future, President Biden is asking Congress to help.

: Morgan Stanley names Ted Pick its next CEO

Morgan Stanley said late Wednesday that Co-President Edward "Ted" Pick will become its Chief Executive, effective Jan. 1.

Key Words: ‘We’re not in Kansas anymore’: Why the 60/40 portfolio might be dead, and what to do now 

"Set it and forget it" made some retirement savers rich for decades — but it won’t anymore. 

Market Extra: Japanese yen sinks to weakest level against the dollar in a year as key BoJ meeting looms

The U.S. dollar touched its highest level against the Japanese yen in a year on Wednesday as rising Treasury yields helped push the greenback higher.

: Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake

Eisai plans to apply for FDA approval of subcutaneous Leqembi by early next year.

Earnings Results: Consumers are cutting back on dental visits, and that’s hammering this stock

People are cutting back on dental and orthodontic visits, and that's weighing heavily on shares of Align Technology Inc. in Wednesday's extended session.
1 2,005 2,006 2,007 2,008 2,009 2,495